Bloomberg the Company

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

StemCells Inc

+ Add to Watchlist


1.0900 USD 0.00000.00%

As of 10:22:38 ET on 02/27/2015.

Snapshot for StemCells Inc (STEM)

Open: 1.0800 Day's Range: 1.0800 - 1.0900 Volume: 33,803
Previous Close: 1.0900 52wk Range: 0.8400 - 2.4300 1-Yr Rtn: -25.34%

Stock Chart for STEM

No chart data available.
  • STEM:US 1.0900
  • 1D
  • 1M
  • 1Y
Interactive STEM Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for STEM

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.5300
Est. EPS (USD) (12/2014) -0.5030
Est. PEG Ratio -
Market Cap (M USD) 74.92
Shares Outstanding (M) 68.73
30 Day Average Volume 353,453
Price/Book (mrq) 4.7531
Price/Sale (ttm) 53.7206
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/12/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for STEM

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for STEM

StemCells, Inc. is a biotechnology company. The Company discovers, develops, and commercializes stem cell-based therapies to treat diseases of the central nervous system, liver, and the pancreas. StemCells seeks to repair or repopulate neural, or other tissue that has been damaged or lost as a result of disease or injury.

Martin M McGlynnPresident/CEOStephen HuhnVP:CNS Clinical Rsch/Chief Medical Ofcr
Gregory T SchiffmanExec VP:Finance/CFOAnn TsukamotoExec VP:Strategic Alliances
More Company Profile & Key Executives for STEM

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil